Cui Xiangmin

SEC CIK: 0001487815

SEC filings (opens in a new tab)

In the past year, 6 open-market sale filings worth $564.4K and no purchases.

Current role at each company

NUVB Nuvation Bio Inc.Directoras of May 26, 2026
BYSI BeyondSpring Inc.10% Owneras of Oct 20, 2025
AARD Aardvark Therapeutics, Inc.10% Owneras of Feb 19, 2025
ALPN Alpine Immune Sciences, Inc.Director, 10% Owneras of May 20, 2024
CGON CG Oncology, Inc.10% Owneras of Apr 9, 2024

Show 1 more company

HLTH Cue Health Inc.Directoras of Sep 30, 2021

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: $564.4K; 6 filings
Net: −$564.4K; Bought minus sold
Companies: 1; With open-market trades

Trades

Every Form 4 that lists Cui Xiangmin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

BYSI BeyondSpring Inc.

10% Owner17 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Aug 11, 2025 (view filing)5:07 PM ET	Jun 17-Aug 4	55 daysLate	Cui Xiangmin and 5 others10% Owner	SSale	−394.4K	$3.05	−$1.20M	−30.7%891.7K after	17 lots
Aug 15, 2025 (view filing)7:11 PM ET	Aug 14-15	1 day	Cui Xiangmin and 5 others10% Owner	SSale	−4.90K	$2.00	−$9.80K	−0.2%1.97M after	2 lots
Aug 20, 2025 (view filing)6:35 PM ET	Aug 18-20	2 days	Cui Xiangmin and 5 others10% Owner	SSale	−54.7K	$1.99	−$109.2K	−2.8%1.92M after	3 lots
Aug 25, 2025 (view filing)7:46 PM ET	Aug 21-25	4 days	Cui Xiangmin and 5 others10% Owner	SSale	−5.71K	$1.77	−$10.1K	−0.3%1.91M after	3 lots
Aug 28, 2025 (view filing)8:39 PM ET	Aug 26-28	2 days	Cui Xiangmin and 5 others10% Owner	SSale	−4.11K	$1.79	−$7.36K	−0.2%1.91M after	3 lots
Sep 3, 2025 (view filing)7:57 PM ET	Aug 29-Sep 3	5 days	Cui Xiangmin and 5 others10% Owner	SSale	−4.87K	$1.78	−$8.67K	−0.3%1.90M after	3 lots
Sep 8, 2025 (view filing)6:55 PM ET	Sep 4-8	4 days	Cui Xiangmin and 5 others10% Owner	SSale	−9.00K	$1.91	−$17.2K	−0.5%1.90M after	3 lots
Sep 11, 2025 (view filing)7:43 PM ET	Sep 9-11	2 days	Cui Xiangmin and 5 others10% Owner	SSale	−21.0K	$1.94	−$40.9K	−1.1%1.87M after	3 lots
Sep 16, 2025 (view filing)7:45 PM ET	Sep 12-16	4 days	Cui Xiangmin and 5 others10% Owner	SSale	−4.11K	$1.85	−$7.60K	−0.2%1.87M after	3 lots
Sep 19, 2025 (view filing)6:03 PM ET	Sep 17-19	2 days	Cui Xiangmin and 5 others10% Owner	SSale	−11.3K	$1.77	−$20.0K	−0.6%1.86M after	3 lots

See all 17 trades at BYSI

AARD Aardvark Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Feb 19, 2025 (view filing)5:44 PM ET	Feb 14	5 days	Cui Xiangmin and 4 others10% Owner	PPurchase	+1.25M	$16.00	+$20.0M	New position958.4K after	2 lots

NUVB Nuvation Bio Inc.

Director2 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Jun 25, 2024 (view filing)	Jun 20-24	5 daysLate	Cui XiangminDirector	PPurchaseClass A Common Stock	+500.0K	$2.98	+$1.49M	+29.8%2.18M after	3 lots
Jun 26, 2024 (view filing)	Jun 25	1 day	Cui XiangminDirector	PPurchaseClass A Common Stock	+277.9K	$2.97	+$825.3K	+12.8%2.45M after

CGON CG Oncology, Inc.